Scientists at MIT have identified 24 protein fragments that could form a new tuberculosis vaccine, offering a potential breakthrough. This next-genera ...
Unraveling mechanisms underlying post-acute SARS-CoV-2 sequelae (long COVID) and finding therapeutic solutions require a full understanding of the causative role of SARS-CoV-2 persistence and/or ...
PROBABLY every physician has been surprised by the sporadic appearance of pulmonary and other forms of tuberculosis in a previously healthy older person in whom recent exposure to an open case of the ...
The Trump administration's new health aid strategy aims to require countries to share critical pathogen data with the U.S. in exchange for funding, raising concerns about fairness and equity in global ...
Exactly 125 years after the discovery of the etiological agent of tuberculosis (TB), the disease remains as threatening as ever. The insufficient control measures in place today were developed in the ...
4don MSNOpinion
RFK Jr.’s Miasma Theory of Health Is Spreading
The NIH is picking up Robert F. Kennedy Jr.’s argument that a healthy immune system can keep even pandemic germs at bay.
Pulmonary diseases pose a major health problem worldwide with millions of affected individuals and dire economic impact.
AllAfrica on MSN
Africa: Private Sector Mobilize Innovation for Health Equity and Resilience At B20 Global Health Breakout
Private sector leaders, philanthropists, and global health experts convened today at the B20 Global Health Breakout, held on the margins of the G20 Leaders' Summit, to spotlight a new wave of ...
In many cases, thoroughly washing or cooking your food is enough to prevent infection from listeria.
In a stunning twist of fate, Africa, the epicentre of HIV, is not just grappling with the virus but also emerging as a hotbed ...
Trained immunity is reshaping our understanding of host defense by demonstrating that innate immune cells once thought to lack memory can be reprogrammed to mount heightened responses to subsequent ...
Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results